Summary
Quest Diagnostics Incorporated (DGX) filed an 8-K on April 23, 2019, to report its financial results for the quarter ended March 31, 2019. The primary focus of this filing is the accompanying press release, which details the company's performance during the first quarter of 2019. Investors should review this release for key financial metrics and operational updates that may influence the company's stock performance. While specific financial figures are not detailed within the 8-K itself, the filing serves as notification that this information is publicly available through the incorporated press release. This document is crucial for understanding Quest Diagnostics' recent financial health, revenue generation, profitability, and any forward-looking statements or guidance provided by management regarding the remainder of the fiscal year.
Key Highlights
- 1Quest Diagnostics (DGX) filed an 8-K on April 23, 2019, announcing Q1 2019 financial results.
- 2The key details are contained within an attached press release (Exhibit 99.1).
- 3The filing pertains to the company's financial condition and results of operations for the quarter ended March 31, 2019.
- 4Investors should refer to the incorporated press release for specific financial data and performance metrics.
- 5This report serves as official notification of the company's quarterly earnings announcement.
- 6No additional financial statements or exhibits beyond the press release were filed with this 8-K.